Cutaneous Mature B-Cell Neoplasm — Trials

Cutaneous Mature B-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

65 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–30 of 30 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05821088	Tafasitamab and Lenalidomide Followed by Tafasitamab and ICE as Salvage Therapy for Transplant Eligible Patients With Relapsed/ Refractory Large B-Cell Lymphoma	active not recruiting	Phase 2	37	David Bond, MDOTHER	1	Jul 20, 2026	clinicaltrials
NCT04799275	Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma	active not recruiting	Phase 2 / Phase 3	422	National Cancer Institute (NCI)NIH	1	Jul 8, 2026	clinicaltrials
NCT03038672	Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas	active not recruiting	Phase 2	54	National Cancer Institute (NCI)NIH	1	May 12, 2026	clinicaltrials
NCT05507541

Data updated 22 days agoSource updated Jul 20, 2026source: clinicaltrials